Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent
申请人:Shinya Kazuo
公开号:US20090124562A1
公开(公告)日:2009-05-14
Provided is a new anti-cancer agent lower in cell toxicity.
The present invention provides the compounds represented by the general formula of “Formula 1” or the salt thereof. The compounds are compounds having an organic group introduced on a particular ketone group of VST that functions to inhibit induction of GRP
78
expression, similarly to VST, and is applicable, for example, as an anti-cancer agent. The compounds are also advantageous in that it is less toxic than VST and has lower adverse reaction.